Nifty

:

23398.10

Sensex

:

74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Login

Nifty
Sensex

:
:

23398.10
74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

65/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

425.10

11-Sep-2026

Open
High
Low
Previous Close

423.25
431.95
418.1
422.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

86404
36645020.9
467.8
268

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,254.49
57.92
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,563.43
0.02%
6.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.37
3.84
5.38

EBITDA CAGR (%)

10 Years
5 Years
3 Years

20.68
0.31
0.54

PAT CAGR (%)

10 Years
5 Years
3 Years

21.48
-8.00
-9.33

P:E (Median)

8 Years
5 Years
3 Years

53.56
53.56
53.56

P:BV (Average)

8 Years
5 Years
3 Years

5.06
5.06
5.06

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.16
23.16
23.16

Earnings Forecasts:

(Updated: 05-09-2026)

Description 2026 2027 2028 2029
Adj EPS 37 17 - -
P/E Ratio 11.49 25.01 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 260.82 226.91 14.94% 252.05 205.02 22.94% 231.09 207.79 11.21% 230.42 204.18 12.85%
Expenses 214.09 194.58 10.03% 206.14 178.38 15.56% 194.79 173.85 12.04% 194.62 165.56 17.55%
EBITDA 46.73 32.33 44.54% 45.91 26.64 72.33% 36.31 33.94 6.98% 35.79 38.62 -7.33%
EBIDTM 17.92% 14.25% 18.21% 12.99% 15.71% 16.33% 15.53% 18.92%
Other Income 0.46 0.89 -48.31% -1.20 0.38 - 0.79 1.86 -57.53% 2.09 0.11 1,800.00%
Interest 9.32 9.23 0.98% 9.44 8.40 12.38% 8.36 4.91 70.26% 9.58 5.18 84.94%
Depreciation 7.71 7.72 -0.13% 7.65 7.84 -2.42% 7.69 4.62 66.45% 7.77 4.30 80.70%
PBT 30.16 16.28 85.26% 27.63 10.78 156.31% 21.05 26.28 -19.90% 20.53 29.26 -29.84%
Tax 7.70 4.20 83.33% 7.05 2.81 150.89% 5.49 6.96 -21.12% 5.59 7.48 -25.27%
PAT 22.46 12.07 86.08% 20.58 7.97 158.22% 15.56 19.32 -19.46% 14.93 21.78 -31.45%
PATM 8.61% 5.32% 8.16% 3.89% 6.73% 9.30% 6.48% 10.67%
EPS 2.24 1.20 86.67% 2.05 0.80 156.25% 1.55 1.93 -19.69% 1.49 2.17 -31.34%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 260.82 223.72 16.58% 251.82 205.02 22.83% 231.41 207.79 11.37% 237.05 204.18 16.10%
Expenses 214.21 190.42 12.49% 204.61 178.65 14.53% 198.43 173.87 14.13% 199.21 165.56 20.32%
EBITDA 46.61 33.30 39.97% 47.21 26.37 79.03% 32.98 33.92 -2.77% 37.84 38.62 -2.02%
EBIDTM 17.87% 14.89% 18.75% 12.86% 14.25% 16.33% 15.96% 18.91%
Other Income 0.46 0.93 -50.54% -1.17 0.39 - 0.79 1.86 -57.53% 2.12 0.11 1,827.27%
Interest 9.32 9.23 0.98% 9.44 8.40 12.38% 8.36 4.91 70.26% 9.58 5.18 84.94%
Depreciation 7.71 7.72 -0.13% 7.65 7.84 -2.42% 7.69 4.62 66.45% 7.77 4.30 80.70%
PBT 30.04 17.27 73.94% 28.95 10.53 174.93% 17.72 26.26 -32.52% 22.60 29.25 -22.74%
Tax 7.73 4.20 84.05% 7.05 2.81 150.89% 5.30 6.96 -23.85% 5.78 7.48 -22.73%
PAT 22.31 13.07 70.70% 21.90 7.72 183.68% 12.42 19.31 -35.68% 16.82 21.77 -22.74%
PATM 8.55% 5.84% 8.70% 3.77% 5.37% 9.29% 7.10% 10.66%
EPS 2.23 1.30 71.54% 2.18 0.77 183.12% 1.24 1.93 -35.75% 1.68 2.17 -22.58%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 974.38 940.48 819.81 806.67 690.62 779.16 487.70 378.84 350.77 305.58 245.52 Net Sales Growth 15.46% 14.72% 1.63% 16.80% -11.36% 59.76% 28.74% 8.00% 14.79% 24.46% Cost Of Goods Sold 430.89 349.09 309.97 339.06 295.46 368.49 226.12 156.47 161.37 128.58 107.42 Gross Profit 543.49 591.39 509.84 467.60 395.16 410.67 261.58 222.37 189.40 177.01 138.10 GP Margin 55.78% 62.88% 62.19% 57.97% 57.22% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% Total Expenditure 809.64 790.13 683.41 659.37 555.97 631.13 403.78 326.72 304.78 266.80 222.57 Power & Fuel Cost - 32.34 18.46 17.61 15.24 11.00 9.94 8.23 3.43 3.58 3.51 % Of Sales - 3.44% 2.25% 2.18% 2.21% 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% Employee Cost - 151.68 127.19 109.67 86.73 85.61 66.22 58.59 46.85 44.62 41.03 % Of Sales - 16.13% 15.51% 13.60% 12.56% 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% Manufacturing Exp. - 134.69 106.44 89.75 72.21 82.20 46.74 43.26 43.16 37.69 28.94 % Of Sales - 14.32% 12.98% 11.13% 10.46% 10.55% 9.58% 11.42% 12.30% 12.33% 11.79% General & Admin Exp. - 70.70 61.77 54.18 44.70 37.97 23.69 32.47 32.32 31.50 27.03 % Of Sales - 7.52% 7.53% 6.72% 6.47% 4.87% 4.86% 8.57% 9.21% 10.31% 11.01% Selling & Distn. Exp. - 41.61 47.57 40.20 31.74 28.38 17.87 17.35 11.36 13.26 9.11 % Of Sales - 4.42% 5.80% 4.98% 4.60% 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% Miscellaneous Exp. - 10.02 12.03 8.89 9.88 17.48 13.20 10.36 6.29 7.57 9.11 % Of Sales - 1.07% 1.47% 1.10% 1.43% 2.24% 2.71% 2.73% 1.79% 2.48% 2.25% EBITDA 164.74 150.35 136.40 147.30 134.65 148.03 83.92 52.12 45.99 38.78 22.95 EBITDA Margin 16.91% 15.99% 16.64% 18.26% 19.50% 19.00% 17.21% 13.76% 13.11% 12.69% 9.35% Other Income 2.14 2.58 3.62 2.18 2.57 3.10 3.73 5.79 4.17 2.86 1.44 Interest 36.70 36.61 24.52 16.79 8.22 5.37 13.63 13.91 10.16 8.88 6.34 Depreciation 30.82 30.83 21.06 17.02 22.28 18.93 16.31 13.86 4.65 4.40 3.68 PBT 99.37 85.48 94.43 115.67 106.72 126.84 57.71 30.13 35.35 28.37 14.37 Tax 25.83 22.34 24.49 29.54 27.02 31.00 13.48 7.44 13.41 13.48 5.35 Tax Rate 25.99% 26.13% 25.93% 25.54% 25.32% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% PAT 73.53 63.15 69.93 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 PAT before Minority Interest 73.53 63.15 69.93 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.55% 6.71% 8.53% 10.68% 11.54% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% PAT Growth 20.26% -9.70% -18.82% 8.08% -16.84% 116.69% 94.93% 3.42% 33.13% 82.71% EPS 7.33 6.30 6.97 8.59 7.95 9.56 4.41 2.26 2.19 1.64 0.90

Description TTM Mar 26 Mar 25 Mar 24
Net Sales 981.10 944.01 819.81 806.67 Net Sales Growth 16.70% 15.15% 1.63% Cost Of Goods Sold 435.41 349.07 309.97 339.06 Gross Profit 545.69 594.94 509.84 467.60 GP Margin 55.62% 63.02% 62.19% 57.97% Total Expenditure 816.46 792.67 683.71 659.37 Power & Fuel Cost - 32.34 18.46 17.61 % Of Sales - 3.43% 2.25% 2.18% Employee Cost - 151.68 127.19 109.67 % Of Sales - 16.07% 15.51% 13.60% Manufacturing Exp. - 134.70 106.44 89.75 % Of Sales - 14.27% 12.98% 11.13% General & Admin Exp. - 71.32 62.06 54.18 % Of Sales - 7.56% 7.57% 6.72% Selling & Distn. Exp. - 43.42 47.57 40.20 % Of Sales - 4.60% 5.80% 4.98% Miscellaneous Exp. - 10.16 12.04 8.89 % Of Sales - 1.08% 1.47% 1.10% EBITDA 164.64 151.34 136.10 147.30 EBITDA Margin 16.78% 16.03% 16.60% 18.26% Other Income 2.20 2.66 3.63 2.18 Interest 36.70 36.61 24.52 16.79 Depreciation 30.82 30.83 21.06 17.02 PBT 99.31 86.55 94.14 115.67 Tax 25.86 22.34 24.49 29.54 Tax Rate 26.04% 25.81% 26.01% 25.54% PAT 73.45 64.21 69.65 86.14 PAT before Minority Interest 73.45 64.21 69.65 86.14 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 7.49% 6.80% 8.50% 10.68% PAT Growth 18.72% -7.81% -19.14% EPS 7.32 6.40 6.94 8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 664.18 601.36 532.56 347.81 269.12 173.44 129.32 75.35 54.14 37.33 Share Capital 10.03 10.03 10.03 9.69 9.69 9.69 9.69 7.78 7.78 7.74 Total Reserves 654.15 591.23 522.53 338.11 259.42 163.74 119.63 67.56 46.35 29.59 Non-Current Liabilities 159.54 180.73 187.93 224.18 65.88 54.96 37.79 17.16 12.54 9.16 Secured Loans 105.04 130.50 153.96 190.68 47.98 35.43 19.52 11.25 4.43 3.20 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.06 3.89 3.42 Long Term Provisions 18.00 17.49 15.38 13.29 12.39 10.23 7.93 1.86 2.26 2.29 Current Liabilities 517.87 387.53 372.05 288.21 186.40 190.96 239.77 217.72 168.55 128.18 Trade Payables 199.08 158.75 166.27 130.26 140.95 111.21 117.07 77.81 75.98 43.74 Other Current Liabilities 57.96 70.14 56.48 38.82 33.30 29.98 22.99 16.28 17.24 20.75 Short Term Borrowings 254.45 154.27 142.02 111.76 6.60 16.32 93.10 84.69 69.17 46.97 Short Term Provisions 6.38 4.38 7.28 7.37 5.55 33.45 6.62 38.95 6.16 16.73 Total Liabilities 1,341.59 1,169.62 1,092.54 860.20 521.40 419.36 406.88 310.23 235.23 174.67 Net Block 491.01 505.99 158.89 159.57 115.17 99.97 82.58 24.45 22.85 21.96 Gross Block 629.87 614.13 246.23 246.28 179.65 148.64 114.98 37.19 31.00 25.65 Accumulated Depreciation 138.86 108.13 87.34 86.71 64.48 48.67 32.40 12.74 8.15 3.68 Non Current Assets 541.33 545.85 492.07 396.08 200.65 131.48 133.58 46.34 37.02 31.42 Capital Work in Progress 22.14 21.82 307.06 169.59 40.87 13.40 30.61 9.63 2.05 0.04 Non Current Investment 2.87 2.81 1.79 0.78 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 23.79 13.17 23.12 64.35 43.65 17.12 18.54 10.16 8.73 7.60 Other Non Current Assets 1.51 2.06 1.21 1.80 0.95 0.98 1.84 2.09 3.38 1.82 Current Assets 800.26 623.78 600.47 464.11 320.75 287.88 273.31 263.89 198.20 143.25 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 324.47 216.87 200.48 183.46 115.57 94.40 122.46 94.28 94.20 63.02 Sundry Debtors 297.40 314.61 329.94 205.47 151.55 124.50 106.97 103.18 80.80 52.12 Cash & Bank 74.36 28.21 13.47 46.69 26.57 13.18 16.37 7.59 7.50 5.64 Other Current Assets 104.04 1.57 3.75 1.79 27.07 55.80 27.50 58.84 15.70 22.47 Short Term Loans & Adv. 102.00 62.52 52.83 26.71 26.21 55.11 26.71 57.95 15.53 22.30 Net Current Assets 282.39 236.24 228.42 175.90 134.35 96.92 33.53 46.17 29.66 15.07 Total Assets 1,341.59 1,169.63 1,092.54 860.19 521.40 419.36 406.89 310.23 235.22 174.67

Description Mar 26 Mar 25 Mar 24
Shareholder's Funds 664.95 601.08 532.56 Share Capital 10.03 10.03 10.03 Total Reserves 654.92 590.94 522.53 Non-Current Liabilities 159.54 180.73 187.93 Secured Loans 105.04 130.50 153.96 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 18.00 17.49 15.38 Current Liabilities 517.85 387.56 372.05 Trade Payables 199.03 158.75 166.27 Other Current Liabilities 57.96 70.14 56.48 Short Term Borrowings 254.45 154.27 142.02 Short Term Provisions 6.41 4.40 7.28 Total Liabilities 1,342.38 1,169.37 1,092.54 Net Block 491.02 505.99 158.89 Gross Block 629.88 614.13 246.23 Accumulated Depreciation 138.86 108.14 87.34 Non Current Assets 540.26 544.84 492.06 Capital Work in Progress 22.14 21.82 307.06 Non Current Investment 1.78 1.78 1.78 Long Term Loans & Adv. 23.81 13.18 23.12 Other Non Current Assets 1.51 2.06 1.21 Current Assets 802.12 624.52 600.48 Current Investments 0.00 0.00 0.00 Inventories 324.47 216.87 200.48 Sundry Debtors 297.40 314.61 329.94 Cash & Bank 76.22 29.02 13.48 Other Current Assets 104.03 1.50 3.75 Short Term Loans & Adv. 101.99 62.52 52.83 Net Current Assets 284.27 236.97 228.43 Total Assets 1,342.38 1,169.36 1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 44.19 122.78 -7.46 -26.59 106.24 87.25 47.10 5.21 -4.82 -4.13 PBT 85.48 94.43 115.67 106.72 126.84 57.71 30.13 35.35 29.95 14.37 Adjustment 65.26 43.79 34.15 29.64 23.18 30.79 24.63 13.35 12.07 9.75 Changes in Working Capital -94.71 7.37 -130.23 -135.25 -10.72 8.15 2.48 -33.52 -30.40 -23.70 Cash after chg. in Working capital 56.03 145.59 19.59 1.11 139.30 96.65 57.24 15.18 11.63 0.42 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.84 -22.81 -27.04 -27.70 -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -30.96 -71.79 -102.40 -190.73 -94.59 -6.69 -42.53 -12.99 -8.84 -4.69 Net Fixed Assets -16.06 -82.66 -137.42 -195.35 -58.48 -16.45 -98.77 -13.77 -7.36 25.62 Net Investments -0.06 -1.02 -1.01 -0.77 0.00 0.00 0.00 0.00 0.00 0.00 Others -14.84 11.89 36.03 5.39 -36.11 9.76 56.24 0.78 -1.48 -30.31 Cash from Financing Activity 32.19 -37.20 82.38 234.31 -6.24 -78.62 -4.21 7.71 14.40 7.41 Net Cash Inflow / Outflow 45.42 13.78 -27.48 16.99 5.41 1.94 0.37 -0.08 0.75 -1.41 Opening Cash & Equivalents 14.91 1.13 28.60 11.61 6.20 4.26 3.90 3.74 2.99 4.28 Closing Cash & Equivalent 60.32 14.91 1.13 28.60 11.61 6.20 4.26 3.66 3.74 2.87

Description Mar 26 Mar 25 Mar 24
Cash From Operating Activity 45.14 122.57 -7.46 PBT 86.55 94.14 115.67 Adjustment 65.26 43.79 34.15 Changes in Working Capital -94.83 7.44 -130.23 Cash after chg. in Working capital 56.98 145.38 19.59 Interest Paid 0.00 0.00 0.00 Tax Paid -11.84 -22.81 -27.04 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -30.96 -70.78 -102.39 Net Fixed Assets -16.06 -82.66 Net Investments -0.06 -1.02 Others -14.84 12.90 Cash from Financing Activity 32.29 -37.20 82.38 Net Cash Inflow / Outflow 46.46 14.59 -27.46 Opening Cash & Equivalents 15.72 1.14 28.60 Closing Cash & Equivalent 62.19 15.72 1.14

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 66.23 59.96 53.11 35.88 27.76 17.89 13.34 9.68 6.96 4.83 ROA 5.03% 6.18% 8.82% 11.54% 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% ROE 9.98% 12.34% 19.57% 25.84% 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% ROCE 12.45% 13.51% 17.56% 23.23% 47.29% 30.05% 21.01% 29.65% 34.10% 24.26% Fixed Asset Turnover 1.96 2.56 3.82 3.76 5.17 3.94 5.14 10.57 11.21 6.77 Receivable days 91.66 106.89 103.93 81.36 59.40 81.43 97.98 93.16 76.39 75.93 Inventory Days 81.07 69.22 74.53 68.14 45.18 76.30 101.05 95.44 90.36 79.39 Payable days 187.07 191.37 159.61 167.52 124.89 184.25 115.05 115.32 80.93 87.99 Cash Conversion Cycle -14.34 -15.25 18.85 -18.02 -20.30 -26.52 83.98 73.27 85.82 67.32 Total Debt/Equity 0.58 0.52 0.60 0.90 0.23 0.32 0.90 1.30 1.47 1.52 Interest Cover 3.33 4.85 7.89 13.98 24.64 5.23 3.17 4.48 4.37 3.27

Description Mar 26 Mar 25 Mar 24
Book Value (Rs.) 66.31 59.93 53.11 ROA 5.11% 6.16% 7.88% ROE 10.14% 12.29% 16.17% ROCE 12.56% 13.48% 15.59% Fixed Asset Turnover 1.96 2.56 3.82 Receivable days 91.39 106.89 128.09 Inventory Days 80.84 69.22 77.83 Payable days 187.06 191.37 178.99 Cash Conversion Cycle -14.82 -15.25 26.94 Total Debt/Equity 0.58 0.52 0.60 Interest Cover 3.36 4.84 7.89

Top Investors:

motilal oswal financial services ltd

icici prudential multicap fund

jagdish n master

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences gets nod to incorporate subsidiary in Philippines
17th Aug 2026, 12:44 PM

The Board of Directors of the company, at its meeting held on August 14, 2026, has approved the same
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback